In-vivo Imaging Market Segmentation:
End user Segment Analysis
The pharmaceutical and biotechnology companies segment in the in-vivo imaging market is anticipated to garner the highest share of 48.5% by the end of 2035. The segment’s upliftment is highly attributed to its extensive dependency on non-invasive imaging to escalate drug development and discovery pipelines. These particular companies are actual investors in ensuring high-end preclinical imaging systems to successfully achieve severe quantitative data on drug biodistribution, pharmacokinetics, treatment efficacy, and target engagement, thereby suitable for boosting the segment for the overall market’s welfare.
Application Segment Analysis
The cancer research segment in the in-vivo imaging market is projected to account for the second-highest share during the forecast period. The segment’s growth is effectively fueled by its ability to enhance cancer prevention, diagnosis, detection, and cure by disclosing the suitable biology of cancer, resulting in efficient therapies and strategies. As per the May 2025 National Cancer Institute, an estimated 2,041,910 new cancer cases have been diagnosed, particularly in the U.S., along with an expected 618,120 deaths to take place by the end of 2025, thus increasing the need for the segment in the market.
Technology Segment Analysis
The magnetic resonance imaging (MRI) segment in the in-vivo imaging market is also expected to steadily grow by the end of the projected timeline. The segment’s development is effectively fueled by its usefulness as an essential diagnostic tool, with the ability to ensure highly detailed images of organs, the nervous system, and soft tissues without the need for harmful radiation. In this regard, the February 2023 MDPI article indicated a clinical study conduction on 87 patients, of which 80% of them received MRI preparation for undergoing the MRI scan without the need for any sedation. This resulted in the success rate to be more than five times, thereby suitable for its integration in the market.
Our in-depth analysis of the in-vivo imaging market includes the following segments:
|
Segment |
Subsegments |
|
End user |
|
|
Application |
|
|
Technology |
|
|
Modality |
|
|
Reagents |
|
|
Business Mode |
|
